- Home
- MKTW vs NTRB Comparison
MKTW vs NTRB Comparison
Compare MKTW & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MKTW | NTRB |
|---|---|---|
| Founded | 1999 | 2016 |
| Country | United States | United States |
| Employees | N/A | 3 |
| Industry | Computer Software: Prepackaged Software | Industrial Specialties |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 39.7M | 44.2M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | MKTW | NTRB |
|---|---|---|
| Price | $17.10 | $3.80 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $20.00 | N/A |
| AVG Volume (30 Days) | ★ 24.9K | 6.0K |
| Earning Date | 05-07-2026 | 05-29-2026 |
| Dividend Yield | ★ 10.33% | N/A |
| EPS Growth | ★ 1183.33 | N/A |
| EPS | ★ 2.31 | N/A |
| Revenue | ★ $512,403,000.00 | N/A |
| Revenue This Year | $1.52 | $30.17 |
| Revenue Next Year | $4.55 | $3,394.36 |
| P/E Ratio | $7.56 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $12.65 | $3.42 |
| 52 Week High | $21.74 | $11.68 |
Technical Indicators
Market Signals| Indicator | MKTW | NTRB |
|---|---|---|
| Relative Strength Index (RSI) | 57.89 | N/A |
| Support Level | $17.57 | N/A |
| Resistance Level | $20.62 | N/A |
| Average True Range (ATR) | 0.87 | 0.00 |
| MACD | -0.03 | 0.00 |
| Stochastic Oscillator | 90.27 | 0.00 |
Price Performance
Historical ComparisonAbout MKTW MarketWise Inc.
Marketwise Inc is a multi-brand subscription services platform providing premium financial research, software, education, and tools for investors. Its products are built for high-value financial research, education, actionable investment ideas, and investment software. It is a digital, direct-to-consumer company offering its research across a variety of platforms, including mobile, desktop, and tablets.
About NTRB Nutriband Inc.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.